Jade Biosciences, Inc. · NASDAQ:JBIO
TCG Crossover GP I, LLC's stake in Jade Biosciences, Inc. fell to 0.20% (Schedule 13G/A)
Event Apr 28, 2025 · Filed May 15, 2025
TCG Crossover GP I, LLC's stake in Jade Biosciences, Inc. fell to 0.20%, 64,023 shares, as a passive investor on Apr 28, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 0.20%
- Shares
- 64,023
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP I, LLC | 0.20% | 64,023 |
| TCG Crossover Fund I, L.P. | 0.20% | 64,023 |
| Chen Yu | 0.20% | 64,023 |
Source
Related
- Jade Biosciences, Inc.
- TCG Crossover GP I, LLC
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026